These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 25444825

  • 21. Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012.
    Kelly HA, Grant KA, Gidding H, Carville KS.
    Euro Surveill; 2014 Oct 16; 19(41):. PubMed ID: 25345520
    [Abstract] [Full Text] [Related]

  • 22. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster.
    Brisson M, Melkonyan G, Drolet M, De Serres G, Thibeault R, De Wals P.
    Vaccine; 2010 Apr 26; 28(19):3385-97. PubMed ID: 20199763
    [Abstract] [Full Text] [Related]

  • 23. Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015.
    Choi JK, Park SH, Park S, Choi SM, Kim SH, Lee DG, Yoo JH, Choi JH, Kang JH.
    Hum Vaccin Immunother; 2019 Apr 26; 15(11):2554-2560. PubMed ID: 31008679
    [Abstract] [Full Text] [Related]

  • 24. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H, Berbers G, Hahné S, Rümke H, van den Hof S, de Wit A, Boot H.
    Vaccine; 2006 May 01; 24(18):3946-52. PubMed ID: 16564115
    [Abstract] [Full Text] [Related]

  • 25. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.
    Gao Z, Gidding HF, Wood JG, MacIntyre CR.
    Epidemiol Infect; 2010 Apr 01; 138(4):457-68. PubMed ID: 19781116
    [Abstract] [Full Text] [Related]

  • 26. Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia.
    Marshall HS, McIntyre P, Richmond P, Buttery JP, Royle JA, Gold MS, Wood N, Elliott EJ, Zurynski Y, Toi CS, Dwyer DE, Booy R.
    Pediatr Infect Dis J; 2013 May 01; 32(5):530-7. PubMed ID: 23249914
    [Abstract] [Full Text] [Related]

  • 27. Consensus: varicella vaccination of healthy children--a challenge for Europe.
    Rentier B, Gershon AA, European Working Group on Varicella.
    Pediatr Infect Dis J; 2004 May 01; 23(5):379-89. PubMed ID: 15131459
    [Abstract] [Full Text] [Related]

  • 28. Varicella: a vaccine preventable disease?
    Watson B.
    J Infect; 2002 May 01; 44(4):220-5. PubMed ID: 12099727
    [Abstract] [Full Text] [Related]

  • 29. [Varicella vaccine].
    Abarca Villaseca K.
    Rev Chilena Infectol; 2006 Mar 01; 23(1):56-9. PubMed ID: 16462966
    [Abstract] [Full Text] [Related]

  • 30. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany.
    Siedler A, Dettmann M.
    Hum Vaccin Immunother; 2014 Mar 01; 10(12):3594-600. PubMed ID: 25483695
    [Abstract] [Full Text] [Related]

  • 31. Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination.
    Avila-Aguero ML, Ulloa-Gutierrez R, Camacho-Badilla K, Soriano-Fallas A, Arroba-Tijerino R, Morice-Trejos A.
    Expert Rev Vaccines; 2017 Mar 01; 16(3):229-234. PubMed ID: 27786560
    [Abstract] [Full Text] [Related]

  • 32. Epidemiology of pediatric herpes zoster after varicella infection: a population-based study.
    Wen SY, Liu WL.
    Pediatrics; 2015 Mar 01; 135(3):e565-71. PubMed ID: 25713285
    [Abstract] [Full Text] [Related]

  • 33. Trends in rates of herpes zoster-related hospitalizations: are they real, are they costly, and are they linked to varicella vaccination?
    Harpaz R, Yawn BP.
    Infect Control Hosp Epidemiol; 2009 May 01; 30(5):495-6; author reply 496-7. PubMed ID: 19344268
    [No Abstract] [Full Text] [Related]

  • 34. Trends in U.S. Community hospitalizations due to herpes zoster: 2001-2015.
    Pham MA, Bednarczyk RA, Becker ER, Orenstein WA, Omer SB.
    Vaccine; 2019 Feb 04; 37(6):882-888. PubMed ID: 30616954
    [Abstract] [Full Text] [Related]

  • 35. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ, Melegaro A, Gay N, Bilcke J, Edmunds WJ.
    Vaccine; 2012 Feb 01; 30(6):1225-34. PubMed ID: 22119592
    [Abstract] [Full Text] [Related]

  • 36. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S, Guzzetta G, Flem E, Mirinaviciute G, Scalia Tomba G, Manfredi P.
    Vaccine; 2018 Feb 14; 36(8):1116-1125. PubMed ID: 29366704
    [Abstract] [Full Text] [Related]

  • 37. [Immunization against varicella and zoster].
    Floret D.
    Bull Acad Natl Med; 2007 Jun 14; 191(6):1051-64; discussion 1064-7. PubMed ID: 18402164
    [Abstract] [Full Text] [Related]

  • 38. Epidemiology of Varicella-Zoster Virus in England and Wales.
    Brisson M, Edmunds WJ.
    J Med Virol; 2003 Jun 14; 70 Suppl 1():S9-14. PubMed ID: 12627480
    [Abstract] [Full Text] [Related]

  • 39. Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004.
    Pérez-Farinós N, Ordobás M, García-Fernández C, García-Comas L, Cañellas S, Rodero I, Gutiérrez-Rodríguez A, García-Gutiérrez J, Ramírez R.
    BMC Infect Dis; 2007 Jun 15; 7():59. PubMed ID: 17570859
    [Abstract] [Full Text] [Related]

  • 40. [Immunization of adults against varicella and herpes zoster].
    Hanslik T, Blanchon T, Alvarez FP.
    Rev Med Interne; 2007 Mar 15; 28(3):166-72. PubMed ID: 17270316
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.